Neurological Disorder Diagnostics Market Size, Share, By Product (Imaging Systems and In-vitro Diagnostics), Disease Indication (Strokes, Multiple Sclerosis, Neurodegenerative Diseases, Headaches, Sleep Disorder, and Others), End-User (Hospitals, Specialt

Neurological Disorder Diagnostics Market Size, Share, By Product (Imaging Systems and In-vitro Diagnostics), Disease Indication (Strokes, Multiple Sclerosis, Neurodegenerative Diseases, Headaches, Sleep Disorder, and Others), End-User (Hospitals, Specialty Clinics, Diagnostic Centers, and Ambulatory Care Centers) and Region - Trends, Analysis, and Forecast till 2035

Neurological disorder diagnostics is the process of evaluating and identifying neurological disorder by performing neurological examination, patient’s medical history, and diagnostic tests, such as MRI and CT scans for brain imaging tests. The demand for neurological diagnostics is rising due to the increasing incidence of neurological disorders, growing patients stress, increasing demand for technological advancements, and early disease diagnosis, further helping to drive target market growth.

Neurological Disorder Diagnostics Market Report Highlights:

By 2035, the target market is expected to increase at a rate of USD 19.7 Billion.

In 2024, the neurological disorder diagnostics market systems size was worth USD 8.66 Billion.

The market is expanding at a CAGR of 8.6%.

By product, the market is being led by the imaging systems segment’s electroencephalogram (EEG) imaging system.

On the basis of disease indication, the neurodegenerative disorder holds the dominant share in the market.

Based on end-user, the hospitals segment is expected to dominate the market during the forecast period.

North America is expected to dominate the market during the projected period.

Asia Pacific is expected to witness fastest growth during the forecast period.

Key Benefits of Purchasing This Report

Gain valuable insights into revenue projections for the overall market and its sub-segments, benefiting industry leaders and new entrants.

Enhance your understanding of the competitive landscape to refine business positioning and optimize go-to-market strategies.

Stay informed on the latest trends in the Neurological Disorder Diagnostics Market, including key drivers, challenges, opportunities, and barriers.

Neurological Disorder Diagnostics Market Key Highlights:

In February 2024: Philips launched their new Azurion neuro biplane system to speed up and improve invasive diagnosis and treatment of neurovascular patients. It is a new image-guided therapy system for diagnosis, image guidance, and therapy assessment solutions for patients with stroke and other neurovascular diseases. The new interventional system is aimed to design a new therapy to achieve better outcomes and enhance 2D & 3D imaging and x-ray detector positioning flexibility. Philips is also partnering with customers to improve productivity and access more sustainable and high-quality healthcare.

Neurological Disorder Diagnostics Market Report Analysis:

Diagnostic Tests for Neurological Disorders: Evaluating and diagnosing damage to the nervous system is complicated and complex. Many of the same symptoms happen in different combinations among the different disorders. Many disorders also don't have definitive causes, markers, or tests. That can make a diagnosis even harder. To diagnose a nervous system disorder, a healthcare provider starts with a complete medical history and physical exam. They may also use one or more of these tests:

CT scan- This imaging test uses a combination of X-rays and computer technology to create detailed images of any part of the body, including bones, muscles, fat, and organs. CT scans are more detailed than general X-rays. They are used to diagnose disorders of the brain, spine, or other parts of the nervous system.

Electroencephalogram (EEG) - This test records the brain's continuous electrical activity through electrodes attached to the scalp.

MRI- This test uses a combination of large magnets, radio waves, and a computer to make detailed images of organs and structures within the body. MRI creates images with much more detail than CT scan without radiation.

Electro diagnostic tests- such as electromyography (EMG) and nerve conduction velocity (NCV). These tests evaluate and diagnose disorders of the muscles and motor neurons. Electrodes are inserted into the muscle or placed on the skin overlying a muscle or muscle group. Electrical activity and muscle response are recorded.

Positron emission tomography (PET) - This test uses a small amount of radioactive material, a camera, and a computer to see how well organs and tissues are working. This test may see the early onset of disease before imaging tests can.

Arteriogram (angiogram) -This X-ray of the arteries and veins detects blockage or narrowing of the blood vessels.

Spinal tap (lumbar puncture) -During this test, a special needle is placed into the lower back, into the spinal canal. This is the area around the spinal cord and nerves. The pressure in the spinal canal and brain can then be measured. A small amount of cerebrospinal fluid (CSF) can be removed and sent for testing to find out if there is an infection or other problems. CSF is the fluid that bathes the brain and spinal cord.

Evoked potentials- This test records the brain's electrical response to visual, auditory, and sensory stimuli.

Myelogram- This test uses dye injected into the spinal canal to make the structure clearly visible on X-rays. This test is used less commonly because MRI is widely available.

Neurosonography- This test uses ultra-high-frequency sound waves. It allows the healthcare provider to analyze blood flow in cases of possible stroke. This includes carotid ultrasound and transcranial doppler.

Ultrasound (sonography) - This imaging test uses high-frequency sound waves and a computer to make images of blood vessels, tissues, and organs. Ultrasounds are used to view internal organs as they function. They also assess blood flow through various vessels.

Segmentation:

By Product:

Imaging Systems

Electroencephalogram (EEG) System

Ultrasound Imaging Systems

Magnetic Resonance Imaging (MRI) System

Computed Tomography (CT) Scanner

Others

In-vitro Diagnostics

Instruments

Next-generation Sequencing

Analysers

Others

Reagent Kits

By Disease Indication:

Strokes

Multiple Sclerosis

Neurodegenerative Diseases

Headaches

Sleep Disorder

Others

By End-User:

Hospitals

Specialty Clinics

Diagnostic Centers

Ambulatory Care Centers

By Region:

North America

U.S.

Canada

Europe

Germany

U.K.

France

Russia

Italy

Spain

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

Australia

Indonesia

Malaysia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

Middle East & Africa

GCC

Israel

South Africa

Rest of Middle East & Africa

List of Key Players in the Market:

Natus

ADDEX THERAPEUTICS

Advanced Brain Monitoring, Inc

Koninklijke Philips N.V

Tevogen Bio

Hitachi High-Tech Corporation

Masimo

NIHON KOHDEN CORPORATION

F. Hoffmann-La Roche Ltd

Medtronic

QURALIS CORPORATION

Atlantic Health System

Fujirebio

Siemens Healthineers AG

ant-neuro.com

Key Questions Answered in This Report

1. What was the size of the Neurological Disorder Diagnostics Market in 2024?

2. What is the expected growth rate of the Neurological Disorder Diagnostics Market during 2025-2035?

3. What are the key factors driving the Neurological Disorder Diagnostics Market?

4. What is the breakup of the Neurological Disorder Diagnostics Market based on the distribution channel?

5. What are the key regions in the Neurological Disorder Diagnostics Market?

6. Who are the key players/companies in the Neurological Disorder Diagnostics Market?

7. What are the drivers, restraints, and opportunities in the Neurological Disorder Diagnostics Market?